These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 7626553)

  • 41. Bone marrow transplantation (BMT) versus immunosuppression for the treatment of severe aplastic anaemia (SAA): a report of the EBMT SAA working party.
    Bacigalupo A; Hows J; Gluckman E; Nissen C; Marsh J; Van Lint MT; Congiu M; De Planque MM; Ernst P; McCann S
    Br J Haematol; 1988 Oct; 70(2):177-82. PubMed ID: 3056497
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Comparison of two types of antithymocyte globulin in the treatment of children with aplastic anemia].
    Xie XT; He W; Shi W; Zhou XX; Qiao XH
    Zhonghua Er Ke Za Zhi; 2016 Apr; 54(4):294-8. PubMed ID: 27055431
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The efficacy of rabbit antithymocyte globulin with cyclosporine in comparison to horse antithymocyte globulin as a first-line treatment in adult patients with severe aplastic anemia: a single-center retrospective study.
    Shin SH; Yoon JH; Yahng SA; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Kim HJ; Cho SG; Kim DW; Min WS; Park CW; Lee JW
    Ann Hematol; 2013 Jun; 92(6):817-24. PubMed ID: 23318980
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of long-term outcome of children with severe aplastic anemia treated with immunosuppression versus bone marrow transplantation.
    Gillio AP; Boulad F; Small TN; Kernan NA; Reyes B; Childs BH; Brochstein JA; Laver J; Castro-Malaspina H; O'Reilly RJ
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):18-24. PubMed ID: 9209737
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunomodulation therapy for severe aplastic anemia--ALG versus ALG plus cyclosporin A.
    Park CW; Han CH; Kim CC; Kim DJ; Kim HK
    Korean J Intern Med; 1989 Jan; 4(1):28-33. PubMed ID: 2487402
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects and Predictive Factors of Immunosuppressive Therapy Combined with Umbilical Cord Blood Infusion in Patients with Severe Aplastic Anemia.
    Zhang X; Li Z; Geng W; Song B; Wan C
    Yonsei Med J; 2018 Jul; 59(5):643-651. PubMed ID: 29869462
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Predictive factors for cure after immunosuppressive therapy of aplastic anemia.
    Viollier R; Tichelli A
    Acta Haematol; 2000; 103(1):55-62. PubMed ID: 10705160
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A retrospective analysis of long-term survival in severe aplastic anemia patients treated with allogeneic bone marrow transplantation or immunosuppressive therapy with antithymocyte globulin and cyclosporin A at a single institution.
    Ellis RJ; Kahn Q; Skikne BS; Mayo MS; Allgood JW; Bodensteiner DM; Deauna-Limayo D; Cook JD
    Mil Med; 2002 Jul; 167(7):541-5. PubMed ID: 12125844
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Therapy of severe aplastic anemia with anti-human thymocyte globulin and androgens: the effect of HLA-haploidentical marrow infusion.
    Doney K; Dahlberg SJ; Monroe D; Storb R; Buckner CD; Thomas ED
    Blood; 1984 Feb; 63(2):342-8. PubMed ID: 6362750
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of severe aplastic anemia with antilymphocyte globulin and androgens.
    Gluckman E; Devergie A; Faille A; Barrett AJ; Bonneau M; Boiron M; Bernard J
    Exp Hematol; 1978 Sep; 6(8):679-87. PubMed ID: 361428
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunosuppressive therapy with horse anti-thymocyte globulin and cyclosporine as treatment for fulminant aplastic anemia in children.
    Yagasaki H; Shichino H; Ohara A; Kobayashi R; Yabe H; Ohga S; Hamamoto K; Ohtsuka Y; Shimada H; Inoue M; Muramatsu H; Takahashi Y; Kojima S
    Ann Hematol; 2014 May; 93(5):747-52. PubMed ID: 24337487
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical outcomes of immunosuppressive therapy for severe aplastic anemia patients with absolute neutrophil count of zero.
    Liu J; Lu XY; Cheng L; Yang Y; Lin SY; Yin H; Liu XQ; Wu XM; He GS
    Hematology; 2019 Dec; 24(1):492-497. PubMed ID: 31221029
    [No Abstract]   [Full Text] [Related]  

  • 53. [Porcine anti-human lymphocyte globulin plus cyclosporine A therapy for severe aplastic anemia].
    Han B; Yan SY; Zou N; Zhang W; Li J; Duan MH; Jiao L; Zhuang JL; Wang SJ; Zhou DB; Zhu TN; Xu Y; Zhao YQ; Shen T
    Zhonghua Xue Ye Xue Za Zhi; 2011 Apr; 32(4):241-4. PubMed ID: 21569706
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment of acquired severe aplastic anemia with antilymphocyte globulin, cyclosporin A, methyprednisolone, and granulocyte colony-stimulating factor.
    Dinçol G; Aktan M; Diz-Küçükkaya R; Yavuz S; Nalçaci M; Oztürk S; Palanduz S; Doğan O; Ağan M
    Am J Hematol; 2007 Sep; 82(9):783-6. PubMed ID: 17506070
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Prognostic factors of immunosuppressive therapy in children acquired aplastic anemia].
    Wang SC; Chen XJ; Zou Y; Yang WY; Liu TF; Zhang L; Chen YM; Guo Y; Zhu XF
    Zhonghua Er Ke Za Zhi; 2009 Aug; 47(8):613-6. PubMed ID: 19951496
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The progression risk factors of children with transfusion-independent non-severe aplastic anemia.
    Wang S; Chen Y; Zou Y; Zheng Y; Zhu X
    Int J Hematol; 2013 Feb; 97(2):210-5. PubMed ID: 23361447
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Results of treatment for severe acquired aplastic anemia in children].
    Ochocka M; Karwacki M; Matysiak M; Armata J; Dłuzniewska A; Bogusławska-Jaworska J; Pejcz J; Kowalczyk J; Skomra S; Radwańska U
    Pediatr Pol; 1995 Mar; 70(3):205-11. PubMed ID: 8657487
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Aplastic anaemia in childhood: prognosis and approach to therapy.
    Windass B; Vowels MR; Hughes DO; White L
    Med J Aust; 1987 Jan; 146(1):15-9. PubMed ID: 3540547
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunosuppressive therapy in patients with aplastic anemia: a single-center retrospective study.
    Jalaeikhoo H; Khajeh-Mehrizi A
    PLoS One; 2015; 10(5):e0126925. PubMed ID: 25970182
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Predicting early response to immunosuppressive therapy in severe aplastic anemia by soluble transferrin receptor assay].
    Yang WR; Xiong YY; Zhang L; Jing LP; Zhou K; Peng GX; Li Y; Ye L; Li Y; Li JP; Fan HH; Song L; Zhao X; Zhang FK
    Zhonghua Xue Ye Xue Za Zhi; 2013 Aug; 34(8):709-13. PubMed ID: 23978026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.